All filters
Slidesets
ARV toxicities and management- Fujie Zhang, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2017
Slidesets
ARV toxicities and management- Fujie Zhang, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2017
Slidesets
Adolescents and HIV: Guiding and Protecting the Vulnerable Population- Dushyantha Jayaweera, MD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2017
Slidesets
Adolescents and HIV: Guiding and Protecting the Vulnerable Population- Dushyantha Jayaweera, MD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2017
Slidesets
Minimising treatment duration and doses | Jordan Feld, MD, MPH
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
Community and harm reduction response to infection and reinfection | Eberhard Schatz
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
Financial models for high- and low income countries | Pieter Walhof
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
Role of generic drugs | Andrew Hill, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
Building global capacity | Stefano Vella
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
National Programs - the Netherlands | Anouk Urbanus
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
National Programs - US | John Ward, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
National Programs - Australia | Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
Progress towards elimination in the Australian prison sector | Andrew Lloyd, MBBS, MD, FRACP, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
People who inject drugs | Olav Dalgard
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
WHO Guidelines and Policies of testing | Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
Challenges in Monitoring (POC) | Isabelle Andrieux-Meyer
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
Creating awareness and sharing the knowledge | Anya Sarang
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
Global Injection Safety Campaign and Prevention Strategies | Arshad Altaf, MD, MBBS
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
Vaccine development and results | Andrea Cox, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
Local situation in Turkey | Serhat Unal, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
Local situation in Russia | Vadim Rassokhin, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
State-of-the-art treatment of Hepatitis B | Cihan Yurdaydin, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
Prospects for Cure | Patrick Kennedy
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016
Slidesets
(Abstract) The effect of lamivudine- versus tenofovir-containing antiretroviral regimen on hepatitis B infection in a cohort of HIV infected long term survivors | A. Temereanca
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2016